Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02999633
Title Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia (ISLAY)
Acronym ISLAY
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sanofi
Indications
Therapies
Age Groups: child | senior | adult
Covered Countries USA | LTU | ITA | HUN | FRA | FIN


No variant requirements are available.